At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02493 MABWELL-B
Not Yet Opened 07-15 15:59:51
24.780
+1.500
+6.44%
High24.940
Low23.500
Vol659.00K
Open23.800
D1 Closing23.280
Amplitude6.19%
Mkt Cap11.08B
Tradable Cap1.17B
Total Shares447.00M
T/O16.20M
T/O Rate1.40%
Tradable Shares47.13M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Mabwell secures NMPA clearance to begin clinical trials of 9MW5211 for vitiligo
The company is an innovative biopharmaceutical enterprise with end-to-end, full-industry-chain integration. Adhering to the vision of "turning innovation from a dream into reality" and upholding the mission of "exploring life to benefit health," it leverages breakthrough, first-in-class innovation to deliver biologic innovators that offer superior efficacy and greater accessibility, thereby addressing unmet clinical needs worldwide. The company's core business encompasses the research and development, manufacturing, and commercialization of innovative medicines and biosimilars. Its principal product portfolio includes antibodies, antibody–drug conjugates, recombinant proteins, small-molecule chemical drugs, and other therapeutic agents. The company has been recognized with numerous awards, including the Shanghai Industrial Talent Development Initiative's "Outstanding Case Award," the Institute of Chartered Accountants in Australia's "Recognized Employer" designation, the Starlight List's "2021 China Biologics Innovation Drug Most Promising Growth Award," as well as top honors on the China Pharmaceutical Talent Brand Ranking and the Most Competitive Brand list.